Search for: "CDI"
Results 141 - 160
of 482
Sort by Relevance
|
Sort by Date
11 Jul 2019, 1:56 pm
If you’re in this predicament, you may be receiving phone calls from multiple other creditors aside from CDI. [read post]
13 Jun 2019, 9:00 pm
AddUp Ingénieur(e) Brevets/Propriété Intellectuelle expérimentés (H/F) - CDI A) L’entreprise Le marché de la Fabrication Additive est en plein essor et se développe en croissance à 2 chiffres depuis de récentes années, notamment au sein de marchés attractifs comme l'aéronautique, le médical ou l'automobile. [read post]
27 May 2019, 9:00 pm
Offre d’emploi CDI Ingénieur(e) Brevets Expérimenté(e) Environnement : Réputé tant en France qu’à l’étranger pour son expertise de la propriété industrielle (PI), le Cabinet Nony conseille et assure la gestion complète des démarches de ses clients pour obtenir et défendre leurs titres de propriété industrielle, brevets et marques. [read post]
30 Apr 2019, 3:04 am
Revise the Non-GAAP CDIs to provide that all non-GAAP financial measures presented in the CD&A are subject to Reg G and Item 10(e) – and that the required reconciliation must be included within the proxy statement or through a link in the CD&A CII says it isn’t seeking a ban on using non-GAAP measures in compensation plans. [read post]
22 Apr 2019, 3:00 am
When the disclosure simplification changes went into effect last fall, the Staff issued Exchange Act Forms CDI 105.09 indicating that companies wouldn’t be required to provide this disclosure in their 10-Qs for the 3rd quarter, but that the disclosure would be required in subsequent 10-Q filings – and for most companies, that means the upcoming Q1 filing. [read post]
28 Mar 2019, 7:01 am
DIB witnesses testified that the current definition of CDI in the DFARS Cyber Rule has become very broad. [read post]
18 Mar 2019, 10:00 pm
Responsable Propriété Industrielle (CDI à Nantes) OSE Immunotherapeutics est une société de biotechnologie en phase clinique qui développe des immunothérapies innovantes, en direct ou via des partenariats, pour l’activation et la régulation immunitaire en immuno-oncologie et dans les maladies auto-immunes. [read post]
15 Mar 2019, 9:17 am
CDI Indiana, LLC, Feb. 27, 2019, U.S. [read post]
13 Mar 2019, 8:00 am
CDI Indiana, LLC, d/b/a CDI, Indianapolis, 18-3080 (U.S. [read post]
6 Mar 2019, 11:23 am
(CDI), Combe Fill Corporation (CFC), and Combustion Equipment Associates, Inc. [read post]
5 Mar 2019, 3:00 am
Here’s an excerpt: As public companies prepare to file their annual reports on Form 10-K for the year ended December 31, 2018, they should consider whether they qualify for smaller reporting company status under the recently amended definition of smaller reporting company, which became effective on September 10, 2018, and the related CDIs updated by Staff of the Division of Corporation Finance on November 7, 2018. [read post]
26 Feb 2019, 3:15 am
” Non-GAAP: Recognizing “Individually Tailored” Measures As this ‘Journal of Accountancy’ article explains, Corp Fin clarified in 2016 that non-GAAP measures that substitute individually-tailored recognition & measurement methods for those of GAAP could violate Rule 100(b) of Regulation G (see CDI 100.04). [read post]
22 Feb 2019, 3:12 am
I could be wrong but I believe non-controversial CDIs go out without Commission input, but more significant guidance – like Staff Legal Bulletins & things like conflict minerals guidance – almost certainly get run past the Commissioners (or at least the Chair) before they are issued by the Staff. [read post]
15 Feb 2019, 3:00 am
Last week, Corp Fin issued new CDIs addressing board diversity disclosure issues. [read post]
11 Feb 2019, 2:56 pm
On February 6, 2019, the Securities and Exchange Commission released two Compliance and Disclosure Interpretations (CDIs) discussing disclosure requirements in instances where a director or board nominee self-identifies specific diversity characteristics, such as race, gender, ethnicity, religion, nationality, disability, sexual orientation and cultural background. [read post]
7 Feb 2019, 3:00 am
Yesterday, Corp Fin issued two identical “Regulation S-K” CDIs – 116.11 and 133.13 – to clarify what disclosure of self-identified director diversity characteristics is required under Item 401 and, with respect to director nominees, under Item 407. [read post]
5 Dec 2018, 8:00 am
CDI Ind., LLC, No. 1:16-cv-02677-JMS-DML (S.D. [read post]
28 Nov 2018, 3:31 am
” Meanwhile, Corp Fin continues its project of overhauling the CDIs, doing so in waves (so far, the CDIs related to smaller-reporting companies, cross-border deals & the last of the telephone interps have been changed). [read post]
15 Nov 2018, 3:05 am
This edition has the latest insights from the first year of pay ratio disclosure – as well as Corp Fin’s recently-updated proxy CDIs. [read post]
8 Nov 2018, 3:00 am
Rule 12b-2: – CDI 130.04 (withdrawn) – CDI 169.01 (withdrawn) – CDI 169.02 (withdrawn) – CDI 169.03 (withdrawn) 2. [read post]
